Developing a pipeline of oncology products, including two clinical stage compounds originated by Niiki Pharma which target pathways in the endoplasmic reticulum in cancer cells.
Active Portfolio Company
www.intezyne.com
Active Portfolio Company
www.intezyne.com
Location: United States, Florida, Tampa
Total raised: $10M
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.10.2017 | Series A | $10M | - |
Mentions in press and media 1
| Date | Title | Description |
| 07.10.2017 | Intezyne Closes Oversubscribed $10M Series A Financing | Intezyne Technologies, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that it closed an oversubscribed $10M Series A Preferred round lead by existing investor Gaston Capital Healthcare Fund (GCH... |